Published in
Springer, Cancer Chemotherapy and Pharmacology, 3(87), p. 337-347, 2020
DOI: 10.1007/s00280-020-04183-0
Links
Tools
A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors
Journal article published in 2020 by
Haeseong Park,
Kerry Williams,
Nikolaos A. Trikalinos,
Sarah Larson,
Benjamin Tan,
Saiama Waqar,
Rama Suresh,
Daniel Morgensztern,
Brian A. Van Tine,
Ramaswamy Govindan,
Jingqin Luo,
A. Craig Lockhart,
Andrea Wang-Gillam 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 